Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Eurobond IPO and Nidan Laboratories and Healthcare IPO.
Eurobond IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Nidan Laboratories and Healthcare IPO is a SME Fixed Price Issue proposed to list at NSE SME.
| Eurobond IPO | Nidan Laboratories and Healthcare IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Fixed Price Issue |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Fedex Securities Pvt Ltd | First Overseas Capital Limited |
| Registrar | Link Intime India Private Ltd | Bigshare Services Pvt Ltd |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
IPO Allotment URL |
The total issue size of Eurobond IPO is up to ₹45.50 Cr whereas the issue size of the Nidan Laboratories and Healthcare IPO is up to ₹50.00 Cr. The final issue price of Eurobond IPO is ₹70.00 per share and of Nidan Laboratories and Healthcare IPO is ₹125.00 per share.
| Eurobond IPO | Nidan Laboratories and Healthcare IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹70.00 per share | ₹125.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ₹7.00 per share | |
| Market Lot Size | 2000 shares | 1000 shares |
| Fresh Issue Size | 65,00,000 shares | |
| Fresh Issue Size (Amount) | up to ₹45.50 Cr | |
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 65,00,000 shares | 40,00,000 shares |
| Issue Size Total (Amount) | up to ₹45.50 Cr | up to ₹50.00 Cr |
Eurobond IPO opens on Dec 14, 2021, while Nidan Laboratories and Healthcare IPO opens on Oct 28, 2021. The closing date of Eurobond IPO and Nidan Laboratories and Healthcare IPO is Dec 16, 2021, and Nov 02, 2021, respectively.
| Eurobond IPO | Nidan Laboratories and Healthcare IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Dec 14, 2021 | Oct 28, 2021 |
| Issue Close | Dec 16, 2021 | Nov 02, 2021 |
| Basis Of Allotment (Tentative) | Dec 21, 2021 | Nov 09, 2021 |
| Initiation of Refunds (Tentative) | Dec 22, 2021 | Nov 10, 2021 |
| Credit of Share (Tentative) | Dec 23, 2021 | Nov 11, 2021 |
| Listing date (Tentative) | Dec 24, 2021 | Nov 12, 2021 |
| Anchor Lockin End date 1 | Jan 20, 2022 | Dec 09, 2021 |
| Anchor Lockin End date 2 | Mar 21, 2022 | Feb 07, 2022 |
Eurobond IPO P/E ratio is , as compared to Nidan Laboratories and Healthcare IPO P/E ratio of .
| Eurobond IPO | Nidan Laboratories and Healthcare IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 82.50% | 99.99% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 60.61% | 71.22% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Eurobond IPO retail investors (RII) are offered 28,36,000 shares while in Nidan Laboratories and Healthcare IPO retail investors are offered 28,36,000 shares. Qualified institutional buyers (QIB) are offered in Eurobond IPO and in Nidan Laboratories and Healthcare IPO.
| Eurobond IPO | Nidan Laboratories and Healthcare IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 3,28,000 shares | 2,00,000 shares |
| QIB | ||
| NII | 28,36,000 shares | 19,00,000 shares |
| RII | 28,36,000 shares | 19,00,000 shares |
| Employee | 5,00,000 shares | |
| Others | ||
| Total | 56,72,000 shares | 38,00,000 shares |
Eurobond IPO subscribed 1.80x in total, whereas Nidan Laboratories and Healthcare IPO subscribed 1.80x.
| Eurobond IPO | Nidan Laboratories and Healthcare IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 1.66x | 0.15x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.92x | 3.44x |
| Employee (times) | 0.14x | |
| Other (times) | ||
| Total (times) | 1.80x | 1.80x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
